Literature DB >> 22461076

The TONIC trial: a step forward in treating pediatric nonalcoholic fatty liver disease.

Naim Alkhouri1, Ariel E Feldstein.   

Abstract

Entities:  

Year:  2012        PMID： 22461076      PMCID： PMC3325147          DOI： 10.1002/hep.24767

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  19 in total

Review 1.  Nonalcoholic fatty liver disease in children.

Authors:  Ali A Mencin; Joel E Lavine
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-03       Impact factor: 4.294

2.  Histopathology of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J Schork; Joel E Lavine
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

3.  NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.

Authors:  Valerio Nobili; Matilde Marcellini; Rita Devito; Paolo Ciampalini; Fiorella Piemonte; Donatella Comparcola; Maria Rita Sartorelli; Paul Angulo
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

4.  A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.

Authors:  J B Schwimmer; M S Middleton; R Deutsch; J E Lavine
Journal:  Aliment Pharmacol Ther       Date:  2005-04-01       Impact factor: 8.171

5.  Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.

Authors:  Miriam B Vos; Ryan Colvin; Patricia Belt; Jean P Molleston; Karen F Murray; Philip Rosenthal; Jeffrey B Schwimmer; James Tonascia; Aynur Unalp; Joel E Lavine
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-01       Impact factor: 2.839

6.  Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Ariel E Feldstein; Rocio Lopez; Tarek Abu-Rajab Tamimi; Lisa Yerian; Yoon-Mi Chung; Michael Berk; Renliang Zhang; Thomas M McIntyre; Stanley L Hazen
Journal:  J Lipid Res       Date:  2010-07-14       Impact factor: 5.922

7.  Vitamin E treatment in pediatric obesity-related liver disease: a randomized study.

Authors:  Pietro Vajro; Claudia Mandato; Adriana Franzese; Edmondo Ciccimarra; Stefania Lucariello; Marcella Savoia; Grazia Capuano; Fiorella Migliaro
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-01       Impact factor: 2.839

8.  Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.

Authors:  Christine Carter-Kent; Lisa M Yerian; Elizabeth M Brunt; Paul Angulo; Rohit Kohli; Simon C Ling; Stavra A Xanthakos; Peter F Whitington; Phunchai Charatcharoenwitthaya; Jason Yap; Rocio Lopez; Arthur J McCullough; Ariel E Feldstein
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

Review 9.  Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

Authors:  Naim Alkhouri; Laura J Dixon; Ariel E Feldstein
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 3.869

10.  Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

Authors:  Valerio Nobili; Melania Manco; Paolo Ciampalini; Anna Alisi; Rita Devito; Elisabetta Bugianesi; Matilde Marcellini; Giulio Marchesini
Journal:  Clin Ther       Date:  2008-06       Impact factor: 3.393
View more
  6 in total

1.  Omega-3 for nonalcoholic fatty liver disease in children.

Authors:  Paul Clerc; Marialena Mouzaki; Ran D Goldman
Journal:  Can Fam Physician       Date:  2019-01       Impact factor: 3.275

Review 2.  Non-Alcoholic Fatty Liver Disease, an Overview.

Authors:  Asia Muhammad Nd
Journal:  Integr Med (Encinitas)       Date:  2019-04

3.  OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Michael Berk; Lisa Yerian; Rocio Lopez; Yoon-Mi Chung; Renliang Zhang; Thomas M McIntyre; Ariel E Feldstein; Stanley L Hazen
Journal:  Dig Dis Sci       Date:  2014-01-25       Impact factor: 3.199

4.  Establishment and Comparison of Juvenile Female Mouse Models of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Authors:  Lishan Zhou; Deliang Liu; Zhiwei Wang; Hui Dong; Xiaohu Xu; Shunchang Zhou
Journal:  Gastroenterol Res Pract       Date:  2018-08-07       Impact factor: 2.260

5.  Psoralea corylifolia L. Attenuates Nonalcoholic Steatohepatitis in Juvenile Mouse.

Authors:  Lishan Zhou; Jianqiao Tang; Xiaoli Xiong; Hui Dong; Juan Huang; Shunchang Zhou; Lingling Zhang; Huan Qin; Suqi Yan
Journal:  Front Pharmacol       Date:  2017-11-30       Impact factor: 5.810

6.  Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Voytek Slowik; Heather Wasserkrug; Ryan T Fischer; Mark Connelly; Amanda D Deacy; Sarah Hampl; James F Daniel
Journal:  Clin Transl Sci       Date:  2020-11-22       Impact factor: 4.689
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.